insulin pumps Archives - Vista Partners LLC

GLP-1s, Hairlines, and the Almost-Pumpers: Why Modular Medical May Be Ready for Its Close-Up -( $LLY $MODD )

by John F. Heerdink, Jr. 4 hours ago 32Views 0Likes

At this point, glucagon-like peptide-1 drugs, or GLP-1s, have become the market’s favorite lifestyle macro-theme, credited with trimming waistlines, lowering A1Cs, and supposedly reshaping everything from snack aisles to airplane seat designs. Yet in 2026, a new subplot is stealing some headlines:…

Winning in the New FDA Era: Why Modular Medical’s Pivot Could Turn “Almost‑Pumpers” into Believers -( $MODD $PODD )

by John F. Heerdink, Jr. 1 day ago 130Views 0Likes

Tribe Public’s (www.TribePublic.com) latest CEO spotlight managed to condense a multi‑year medtech inflection point into a crisp half hour—and still leave investors wanting a few more slides. On May 1, 2026, Modular Medical (NASDAQ: MODD) CEO Jeb Besser joined Tribe Public’s members…

From Shopping Carts to Smart Carts: Walmart’s Digital Health Push Meets Lilly’s GLP‑1 Boom – ( $AMGN $LLY $MODD $NVO $PFE $WMT )

by John F. Heerdink, Jr. April 20, 2026 125Views 0Likes

Walmart’s (WMT) latest move into digital health reads less like a retail side-hustle and more like an opening bell in the next leg of the GLP‑1 trade, with syringes, smartphones, and stock tickers all lining up on aisle 7. As weight‑loss drugs…

Why Tandem Diabetes Care’s Convertible Notes and Modular Medical’s Pivot Pump Matter for Diabetes Investors -( $MDT $MODD $PODD $TNDM )

by John F. Heerdink, Jr. February 24, 2026 232Views 0Likes

Tandem Diabetes Care’s (TNDM) latest trip to the capital markets reads less like a distress signal and more like a company quietly extending its runway in a race it fully intends to finish. At the same time, a familiar name in diabetes…

Year of the Horsepower: Insulet’s Earnings Sprint and Modular Medical’s Quiet Canter -( $MODD $PODD )

by John F. Heerdink, Jr. February 18, 2026 434Views 0Likes

Insulet’s (PODD) latest numbers read like the balance sheet of a very determined racehorse: fast, disciplined, and still eager for the next lap, even as a promising upstart named Modular Medical trots onto the same track. Insulet’s Earnings: Hitting a Full Gallop…

Can Modular Medical Crack the “Almost‑Pumper” Code? Inside the Bull Case for MODD’s Pivot System -( $MODD $PODD $TNDM )

by John F. Heerdink, Jr. February 6, 2026 431Views 0Likes

Modular Medical’s (NASDAQ: MODD) Pivot insulin delivery system is quietly building a credible bull case that now extends beyond regulatory momentum and leadership credentials into hard operational execution. With the company achieving a key manufacturing milestone for its Pivot tubeless insulin patch…

Tag: insulin pumps

GLP-1s, Hairlines, and the Almost-Pumpers: Why Modular Medical May Be Ready for Its Close-Up -( $LLY $MODD )

Winning in the New FDA Era: Why Modular Medical’s Pivot Could Turn “Almost‑Pumpers” into Believers -( $MODD $PODD )

From Shopping Carts to Smart Carts: Walmart’s Digital Health Push Meets Lilly’s GLP‑1 Boom – ( $AMGN $LLY $MODD $NVO $PFE $WMT )

Why Tandem Diabetes Care’s Convertible Notes and Modular Medical’s Pivot Pump Matter for Diabetes Investors -( $MDT $MODD $PODD $TNDM )

Year of the Horsepower: Insulet’s Earnings Sprint and Modular Medical’s Quiet Canter -( $MODD $PODD )

Can Modular Medical Crack the “Almost‑Pumper” Code? Inside the Bull Case for MODD’s Pivot System -( $MODD $PODD $TNDM )

Your Guide To Staying Informed In The Markets